Clinical Trial Update: Hydrogen Water Intervention With Heart Rate Variability as an Outcome Biomarker in ME/CFS [NA]

View source ↗

Summary

A ClinicalTrials.gov update indicates Stony Brook University is recruiting a study evaluating hydrogen water with heart rate variability as an outcome biomarker…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fatigue Syndrome

Drugs mentioned

• Hydrogen water (hydrogen-rich water)

Snippet

Sponsor: Stony Brook University | Conditions: Chronic Fatigue Syndrome | NA | Status: RECRUITING